Sarolaner for Dogs: Complete Guide to Flea and Tick Control
Everything pet owners need to know about sarolaner (Simparica) for treating flea and tick infestations in dogs.

Sarolaner for Dogs: Everything You Need to Know
Sarolaner, commonly known by its brand name Simparica®®, is a trusted oral medication used to treat and control flea and tick infestations in dogs. As a highly effective ectoparasiticide, sarolaner has become a popular choice among veterinarians and pet owners for maintaining year-round protection against these common parasites. This comprehensive guide covers everything you need to understand about sarolaner, from how it works to potential side effects and dosing instructions.
What Is Sarolaner?
Sarolaner is an oral medication belonging to the isoxazoline class of drugs, specifically designed to treat and control flea and tick infestations in dogs. When administered as directed, the dog ingests sarolaner, and the medication is distributed throughout the dog’s body. This systemic distribution creates an effective protective barrier that works when parasites attempt to feed on your dog’s blood.
The mechanism is straightforward yet highly effective: when fleas or ticks bite an infected dog, they are exposed to the drug during their blood meal and are subsequently killed. This method of parasite elimination is significantly more reliable than topical treatments because it eliminates issues associated with washing off or being accidentally licked away by the pet.
Beyond its use as a standalone treatment, sarolaner is also available in combination products designed for both dogs and cats, expanding its versatility in multi-pet households.
How Sarolaner Works
Sarolaner belongs to a class of medications called isoxazolines, which eliminate fleas and ticks through a sophisticated neurological mechanism. The drug works by overexciting the nervous system of parasites, causing paralysis and ultimately death.
Specifically, sarolaner inhibits arthropod chloride-gated gamma aminobutyric acid (GABA) and glutamate channels in the neuromuscular junction. This action disrupts normal neural communication in fleas and ticks while remaining safe for dogs because mammalian glutamate receptors function differently from invertebrate glutamate receptors. This selective toxicity is what makes sarolaner an effective and relatively safe option for canine parasite control.
Dosage and Administration
Sarolaner is designed to provide dogs with sustained protection against fleas and ticks when given orally once a month. The appropriate monthly dose is a minimum of 2 mg/kg body weight. This oral formulation offers significant advantages over topical alternatives:
- Consistent performance throughout the month without loss due to bathing or swimming
- No risk of medication being unknowingly applied to fur or licked off by the pet
- Significantly decreased drug exposure to humans and other animals in the household
Simparica comes as flavored, chewable tablets and is available in multiple sizes to accommodate dogs of various weights: 5, 10, 20, 40, 80, and 120 mg tablets. Your veterinarian will determine the correct dose based on your dog’s weight and recommend the appropriate tablet size or combination of tablets for optimal dosing.
Effectiveness Against Fleas
Clinical studies have demonstrated remarkable efficacy of sarolaner against flea infestations. The medication kills adult fleas within 4 hours of administration and achieves a 100% kill rate against pre-existing experimental infestations within 12 hours. When dogs are challenged with re-infestation, sarolaner maintains a kill rate of 98% or greater within 8 hours of exposure to new fleas for up to 28 days.
In simulated home environments already contaminated with flea eggs, sarolaner treatment reduced flea counts by more than 95% at 14 days and completely eradicated infestations after two doses (two months) because of its ability to kill fleas before they could lay eggs. Field efficacy studies have shown that monthly dosing with sarolaner maintained a kill rate exceeding 98% at 24 hours after re-infestation for 90 days.
Additionally, sarolaner is effective as part of a treatment strategy for Flea Allergy Dermatitis (FAD), a common condition where dogs develop allergic reactions to flea saliva. By providing consistent flea control, sarolaner helps prevent the allergic responses that cause itching and skin inflammation in sensitive dogs.
Effectiveness Against Ticks
Beyond flea control, sarolaner provides excellent protection against multiple tick species. The medication has been approved for treatment and control of tick infestations, including the American dog tick, black-legged tick, brown dog tick, lone star tick, and Gulf Coast tick.
A particularly important advancement in tick protection is sarolaner’s ability to prevent Borrelia burgdorferi infections, which cause Lyme disease in dogs. This prevention capability exists because sarolaner kills Ixodes scapularis vector ticks, the primary transmitters of the bacteria that causes Lyme disease. This makes sarolaner an excellent choice for dogs living in or traveling to areas where Lyme disease is prevalent.
Duration of Action
This long-acting medication lasts for at least four to six weeks and may extend longer in pets with kidney or liver disease. The extended duration of action is one of the significant advantages of sarolaner, as it provides consistent protection throughout the month without requiring frequent applications or administration.
Combination Products
Sarolaner is available in several combination formulations that provide broader parasite protection:
- Simparica Trio: Contains sarolaner, moxidectin, and pyrantel for prevention of heartworm disease, treatment of fleas and ticks, and treatment of roundworms and hookworms
- Revolution Plus (for cats): Contains sarolaner and selamectin for prevention of sarcoptic mange, ear mites, heartworms, and treatment of feline-specific parasites
Potential Side Effects and Safety Considerations
When sarolaner is used according to label guidelines, adverse effects noted during drug approval were minimal. However, postapproval monitoring has revealed reports of some dogs experiencing neurologic signs after receiving sarolaner and other isoxazoline compounds.
Serious adverse reactions are rare but may occur. If any of the following signs develop, stop giving sarolaner and contact your veterinarian immediately:
- Lack of coordination
- Difficulty walking
- Trembling
- Shaking
Other side effects may occur. If you notice anything unusual in your dog’s behavior or health following administration, contact your veterinarian immediately. In clinical trials, one dog exhibited lethargy, ataxia, elevated third eyelids, and inappetence one day after receiving sarolaner concurrently with ivermectin/pyrantel pamoate; these signs resolved within 24 hours.
The FDA maintains that isoxazolines are still safe for most animals, though the prevalence of and potential risk factors for neurologic adverse effects are currently unknown. The agency continues to monitor reports and provide guidance to veterinarians and pet owners.
Drug Interactions and Precautions
While sarolaner is generally well-tolerated, it is important to inform your veterinarian about all medications and supplements your dog is currently taking. Concurrent administration with certain other medications, particularly those affecting the nervous system, should be carefully considered and monitored by your veterinary professional.
Storage and Handling
Sarolaner tablets should be stored according to package instructions, typically at room temperature away from moisture and excessive heat. Keep all medications out of reach of children and pets who are not receiving the medication. If your dog accidentally ingests an extra dose, contact your veterinarian or poison control immediately.
Comparison with Other Flea and Tick Treatments
| Characteristic | Sarolaner (Simparica) | Topical Treatments | Spinosad |
|---|---|---|---|
| Route of Administration | Oral chewable | Topical liquid | Oral |
| Frequency | Monthly | Monthly or every 3 months | Varies |
| Flea Kill Rate (Day 1) | ≥99.2% | Variable | ≥89.7% |
| Water Resistant | Yes | No | N/A |
| Tick Protection | Multiple species | Varies by brand | Limited |
| Lyme Disease Prevention | Yes | Some products | No |
When to Use Sarolaner
Sarolaner is appropriate for dogs with active flea or tick infestations and as a preventive medication during parasite season. It is particularly recommended for:
- Dogs with flea allergy dermatitis requiring consistent flea control
- Dogs living in areas where Lyme disease is prevalent
- Multi-pet households where topical treatments could be transferred between animals
- Dogs that spend significant time in water or require frequent bathing
- Owners seeking a once-monthly oral alternative to topical treatments
Frequently Asked Questions (FAQs)
Q: How quickly does sarolaner kill fleas?
A: Sarolaner begins killing fleas within 4 hours of administration and achieves a 100% kill rate against pre-existing infestations within 12 hours.
Q: Can sarolaner be given with other medications?
A: Always inform your veterinarian about all medications your dog is taking. While sarolaner is generally safe, certain combinations should be monitored carefully.
Q: What should I do if my dog vomits after taking sarolaner?
A: Contact your veterinarian immediately to determine if a replacement dose is necessary or if any intervention is needed.
Q: Is sarolaner safe for puppies?
A: Consult your veterinarian about the appropriate age and weight for sarolaner administration. Your vet can recommend the safest parasite control options for puppies.
Q: How long does sarolaner protection last?
A: Sarolaner provides protection for at least 4 to 6 weeks, with protection potentially extending longer in dogs with kidney or liver disease.
Q: Can cats take sarolaner?
A: Yes, sarolaner is available in combination products for cats, such as Revolution Plus, which contains sarolaner and selamectin for comprehensive parasite protection.
Q: What should I do if I notice neurologic signs after giving sarolaner?
A: Stop giving sarolaner immediately and contact your veterinarian right away if your dog shows signs of trembling, shaking, lack of coordination, or difficulty walking.
Conclusion
Sarolaner represents a significant advancement in canine parasite control, offering pet owners a reliable, convenient, and highly effective monthly oral medication for treating and preventing flea and tick infestations. Its superior efficacy, water-resistant properties, and ability to prevent Lyme disease make it an excellent choice for many dogs. However, as with any medication, it is essential to use sarolaner only as directed by your veterinarian and to report any unusual side effects immediately. When used appropriately, sarolaner provides months of protection, allowing your dog to enjoy a parasite-free life while you have peace of mind knowing your pet is protected.
References
- Sarolaner Use in Dogs — Today’s Veterinary Practice. 2024. https://todaysveterinarypractice.com/pharmacology/sarolaner-use-in-dogs/
- Sarolaner | VCA Animal Hospitals — VCA Animal Hospitals. 2024. https://vcahospitals.com/know-your-pet/sarolaner
- Efficacy and safety of sarolaner (Simparica) in the treatment of flea and tick infestations in dogs — National Center for Biotechnology Information (NCBI). 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5559772/
- Simparica, INN-sarolaner: Product Information — European Commission Health and Food Safety. 2020. https://ec.europa.eu/health/documents/community-register/2020/20200812148638/anx_148638_en.pdf
- Revolution and Revolution Plus for Cats and Dogs — PetMD. 2024. https://www.petmd.com/pet-medication/revolution
- Simparica Product Information — Zoetis. 2024. https://www.zoetisus.com/products/dogs/simparica/
Read full bio of Sneha Tete










